PASADENA, Calif.--(BUSINESS WIRE)-- Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that preclinical data on ARO-INHBE, an investigational RNAi-based medicine for the treatment of ...

Eli Lilly is gaining on rival Novo Nordisk as its dual GIP/GLP-1 med tirzepatide—fresh off an approval pit stop in diabetes—slides into the FDA fast lane. Thursday, Lilly said the FDA flagged its drug ...

Notes: 1) Observed values, no imputation for missing data. 2) Includes all participants who met the criteria for MetS at baseline and enough MetS component Week 13 data collected to determine MetS ...

PALO ALTO, Calif.--(BUSINESS WIRE)--Digbi Health, the leader in precision biology-based telehealth care for three of the top four healthcare costs - Obesity, T2D, and Digestive Health - announced ...

Obesity now affects more than one in five children in the United States, and while there are effective, recommended interventions, availability is limited for most children. In two new studies, Yale ...

BOSTON--(BUSINESS WIRE)--Today, Form Health, the leading provider of science-based obesity care in the United States, announced a new program to prevent progression from overweight to obesity.

Although obesity is a prevalent and complex chronic disease, training for physicians remains generally inadequate. And while fellowship training in obesity medicine is now available at multiple ...

Karli Burridge’s interest in obesity medicine began shortly after earning her PA degree and led her to cofound PAs in Obesity Medicine and Gaining Health, which help clinicians start obesity treatment ...